Trial Name:

ICC 1802
Intro: Cytokine Genotypes and Risk of Depression Syndromes in Patients Undergoing Radiotherapy for Prostate Cancer, and Efficacy of Treatment with Bupropion
Condition:
Description: The purpose of this study is to: 1) measure the number of men who get symptoms of depression during radiotherapy for prostate cancer, and 2) understand who is more likely to get depression symptoms during radiotherapy, and to treat the symptoms if they occur
Criteria:
  1. Age 18-75, able to informed consent
  2. Initiating radiation therapy alone, either external beam or brachytherapy, for localized carcinoma of the prostate, without associated chemotherapy
  3. No significant current neuropsychiatric diagnoses or current psychiatric treatment
  4. No current immunotherapy or immunosuppressant treatment, hematologic malignancy or other immunologic disorder
Contact: For Cancer Information, Current Clinical Trials, and Referral to a Physician please call (216) 844-5432 or (800) 641-2422

Participant Confidentiality:

All information regarding participation in Clinical Trials is treated with the utmost confidentiality. University Hospitals Case Medical Center and the Division of Clinical Research recognize and respect the confidentiality of this information. Access to information related to clinical trials and their participants is restricted to authorized clinical trials personnel only.

Back
   
In This Section